Status:
COMPLETED
Evaluation of Patients With Known or Suspected Heart Disease
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Peripheral Artery Disease
Coronary Disease
Eligibility:
All Genders
Brief Summary
In this study researchers will admit and evaluate patients with known or suspected heart disease referred to the Cardiology Branch of the National Heart, Lung, and Blood Institute (NHLBI). Patients p...
Detailed Description
The principal mission of the NIH is the conduct of research that elucidates biological mechanisms, pathogenesis, and treatment of disease. Patients with known or suspected cardiovascular diseases are ...
Eligibility Criteria
- INCLUSION CRITERIA:
The following is a representative list of the types of patient presentations and potential diagnoses eligible for this protocol:
- Coronary artery disease with angina or inducible myocardial ischemia as determined by noninvasive testing.
- Cardiomyopathies including congestive phenotypes.
- Peripheral artery disease with intermittent claudication or limb-threatening ischemia.
- Renovascular disease with uncontrolled hypertension, intermittent pulmonary edema, or evidence of ischemic nephropathy.
- Upper extremity peripheral artery disease.
- Diabetes with heart failure.
- Pulmonary hypertension.
EXCLUSION CRITERIA:
Pregnancy, for those patients who require catheterization-based diagnostics.
Inability to provide informed consent.
Key Trial Info
Start Date :
May 10 1992
Trial Type :
OBSERVATIONAL
End Date :
January 6 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00001313
Start Date
May 10 1992
End Date
January 6 2009
Last Update
July 2 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Suburban Hospital
Bethesda, Maryland, United States, 20814
2
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892